Company Filing History:
Years Active: 2014-2024
Title: Zhenping Wu: Innovator in Pharmaceutical Chemistry
Introduction
Zhenping Wu is a prominent inventor based in Shanghai, China, known for his significant contributions to the pharmaceutical field. With a total of nine patents to his name, he has made remarkable advancements in drug development and formulation.
Latest Patents
Among his latest patents is a groundbreaking invention related to crystalline forms of (s)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazine-7-yl)ethyl)amino)pyrimidine-5-carbonitrile, which serves as an inhibitor of phosphatidylinositol-3-kinase. This invention provides various crystalline forms, solvates, and pharmaceutical compositions, along with methods for their preparation and use. Another notable patent involves the pharmaceutically acceptable salts of the compound (S)-7-(4-(1-(methylsulfonyl)piperidin-4-yl)phenyl)-N-(morpholin-2-ylmethyl)pyrido[3,4-b]pyrazin-5-amine, including its crystalline forms and solvates, as well as the associated pharmaceutical compositions and methods of preparation.
Career Highlights
Zhenping Wu has worked with notable companies in the pharmaceutical industry, including Hutchison Medipharma Limited and Hutchmed Limited. His work has focused on developing innovative solutions that address critical health challenges.
Collaborations
Throughout his career, Zhenping has collaborated with esteemed colleagues such as Wenji Li and Ling Feng, contributing to a dynamic research environment that fosters innovation.
Conclusion
Zhenping Wu's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact drug development and improve therapeutic options for patients.